TOVX vs TPR · rev $300.0K vs P/E 46, rev $8.00B
Theriva Biologics Inc. (TOVX) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
TOVX currently screens at market cap $12.4M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the TOVX and TPR stock pages for the full models.
Not investment advice.